Lv2
190 积分 2021-01-22 加入
Combined rituximab, bendamustine, and dexamethasone chemotherapy for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma: a multicenter phase II study
4个月前
已完结
Rituximab-related viral infections in lymphoma patients
4个月前
已完结
Long-term efficacy and toxicity of rituximab plus fludarabine and mitoxantrone (R-FM) for gastric marginal zone lymphoma: a single-center experience and literature review
4个月前
已完结
Glofitamab in relapsed/refractory diffuse large B‐cell lymphoma: Real‐world data
4个月前
已完结
Relapse after glofitamab has a poor prognosis and rates of CD20 loss are high
4个月前
已完结
Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma
4个月前
已完结
Glofitamab as a salvage treatment for B‐cell lymphomas in the real world: A multicenter study in Taiwan
4个月前
已完结
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
5个月前
已完结
Outcomes of allogeneic hematopoietic stem cell transplantation in R/R DLBCL patients with failure of CAR-T therapy
9个月前
已完结
Prognostic predictors for patients with hepatocellular carcinoma receiving adjuvant transcatheter arterial chemoembolization
10个月前
已完结
皖公网安备34019202002308
